Large-scale testing (Phase 3)UnknownNCT02633189
What this trial is testing
Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer
Who this might be right for
Non-squamous Non-small Cell Lung Cancer
National Cancer Institute, Naples 200